reference/4753588

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/4753588

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
endingPage	616
issn	0022-1899 1537-6613
issueIdentifier	4
pageRange	608-616
publicationName	The Journal of Infectious Diseases
startingPage	608
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_51f32f76439dbaa0bfc5d435fb3fbabd http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c04fd0c1eda847c5e722e761bd859dc8 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_4ab6d881c7628f3119272787513ea95a http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_487baf6554eb36bb22c6138d90a7c50f http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_81ce53ab3865058bce20a95d26a61996
bibliographicCitation	Jia P, Zhang Y, Xu J, Zhu M, Peng S, Zhang Y, Zhao J, Li X, Mi K, Yan D, Wang Y, Yu L, Lu Y, Shi H, Cen S. IMB-BZ as an Inhibitor Targeting ESX-1 Secretion System to Control Mycobacterial Infection. J Infect Dis. 2022 Feb 15;225(4):608–16. doi: 10.1093/infdis/jiab486. PMID: 34558604.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d98448b8cfa70e115a9787939656168a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_554053cfcf288438a7babdb1970bca40 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f0d8f164487b5e4388f161ff315abf6b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f07a2ac03eecbedb3647fbe3eda050e3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d13ced986e0eb7e15dc94790c9e3d864 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e3dbfc60c1e37d7191d350d189e8c8fb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c97e7a0420aacca306ea04bf54f086cd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b3f3f7d1c5c280d7336ff1d99bfe0b5b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_00c4642bee8a0d1c99624f986da48a58 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1bae0f3d0c7b250510ef9b2247f49ce1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7c9f7218a3a5e2dd7bc7b23b6c2b76e9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-6100-0547 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d8f8f763037f2731664644d6e7d6e204 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_503b0c03e69a6a0e9c37341f33bd9194 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_742169a09f3965fb38078eb983a5f3b7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ed186ddbc797326e520bf65de551a653
date	2021-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1093/infdis/jiab486 https://pubmed.ncbi.nlm.nih.gov/34558604
isPartOf	https://portal.issn.org/resource/ISSN/0022-1899 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4830 https://portal.issn.org/resource/ISSN/1537-6613
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	IMB-BZ as an Inhibitor Targeting ESX-1 Secretion System to Control Mycobacterial Infection
discusses	http://id.nlm.nih.gov/mesh/M0001515 http://id.nlm.nih.gov/mesh/M0002130 http://id.nlm.nih.gov/mesh/M000605596
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000069377Q000378 http://id.nlm.nih.gov/mesh/D009169 http://id.nlm.nih.gov/mesh/D014376Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000995Q000494 http://id.nlm.nih.gov/mesh/D014774 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D001426Q000378
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8552 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9505

Total number of triples: 52.